Key result
Individualized treatment for pediatric postural orthostatic tachycardia syndrome requires comprehensive assessment of clinical characteristics, physiological changes, and biochemical markers.
Why the study?
Comprehensive assessment of clinical characteristics, physiological changes, and biochemical markers is necessary to select appropriate individualized therapy for postural orthostatic tachycardia syndrome.
This review highlights the mechanisms underlying pediatric POTS and emphasizes the importance of comprehensive assessment for individualized management.
May inform individualized pediatric POTS assessment; hypothesis-generating and requires prospective validation before practice change.
Postural orthostatic tachycardia syndrome (POTS) represents chronic orthostatic intolerance. Patients usually suffer from presyncopal symptoms, such as lightheadedness, headache, blurred vision, and fatigue. Central hypovolemia, peripheral vascular dysfunction, and a hyperadrenergic state may contribute to the pathogenesis of POTS. It is necessary to comprehensively assess the clinical characteristics, physiological changes, and biochemical markers to select an appropriate therapy. Since the introduction of the concept of individualized treatment for POTS, great progress has been made in the field.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2024) conducted a review in Pediatric postural orthostatic tachycardia syndrome (POTS). Individualized management was evaluated. Individualized treatment for pediatric postural orthostatic tachycardia syndrome requires comprehensive assessment of clinical characteristics, physiological changes, and biochemical markers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: